A 4 part series on NHS funding mechanisms, published in Clinical Pharmacist.
Trends in NHS funding: patient access schemes
Patient access schemes allow manufacturers to subsidise the cost of innovative medicines used by the NHS. But as more of these schemes are approved, the administrative burden must be constrained
Clinical Pharmacist 2010;2:319-322 (October 2010)
Trends in NHS funding: additional private care
When a patient is unable to receive a potentially beneficial treatment on the NHS, he or she is entitled to pay for it privately without losing the right to NHS care. Such is the essence of “additional private care”
Clinical Pharmacist 2010;2:281-282 (September 2010)
Trends in NHS funding: individual funding requests
You have a patient who you believe will benefit from a medicine that is not routinely funded by their primary care trust. Here we look at how such individual funding requests can be handled by hospitals
Clinical Pharmacist 2010;2:241-242 (July/August 2010)
Trends in NHS funding:
payment by results
Now more than ever pharmacists must think beyond the clinical
appropriateness of medicines to the financial implications of
therapeutic choices. This month we take a look at Payment by Results
Clinical Pharmacist 2010;2:201-202 (June 2010)
